172 related articles for article (PubMed ID: 16078840)
1. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.
Zhang HZ; Kasibhatla S; Kuemmerle J; Kemnitzer W; Ollis-Mason K; Qiu L; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
J Med Chem; 2005 Aug; 48(16):5215-23. PubMed ID: 16078840
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
[TBL] [Abstract][Full Text] [Related]
3. The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach.
Jessen KA; English NM; Yu Wang J; Maliartchouk S; Archer SP; Qiu L; Brand R; Kuemmerle J; Zhang HZ; Gehlsen K; Drewe J; Tseng B; Cai SX; Kasibhatla S
Mol Cancer Ther; 2005 May; 4(5):761-71. PubMed ID: 15897240
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents.
Kemnitzer W; Kuemmerle J; Zhang HZ; Kasibhatla S; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Aug; 19(15):4410-5. PubMed ID: 19500976
[TBL] [Abstract][Full Text] [Related]
5. Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay.
Cai SX; Nguyen B; Jia S; Herich J; Guastella J; Reddy S; Tseng B; Drewe J; Kasibhatla S
J Med Chem; 2003 Jun; 46(12):2474-81. PubMed ID: 12773051
[TBL] [Abstract][Full Text] [Related]
6. Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the carboxamide group.
Kemnitzer W; Sirisoma N; Nguyen B; Jiang S; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jun; 19(11):3045-9. PubMed ID: 19394823
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Crogan-Grundy C; Labreque D; Bubenick M; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2008 Feb; 51(3):417-23. PubMed ID: 18197614
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Zhao J; Crogan-Grundy C; Xu L; Lamothe S; Gourdeau H; Denis R; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2007 Jun; 50(12):2858-64. PubMed ID: 17497765
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors.
Subba Rao AV; Vishnu Vardhan MV; Subba Reddy NV; Srinivasa Reddy T; Shaik SP; Bagul C; Kamal A
Bioorg Chem; 2016 Dec; 69():7-19. PubMed ID: 27656775
[TBL] [Abstract][Full Text] [Related]
11. A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets.
Cai SX; Drewe J; Kasibhatla S
Curr Med Chem; 2006; 13(22):2627-44. PubMed ID: 17017915
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
13. Discovery of substituted 4-anilino-2-arylpyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 2. Structure-activity relationships of the 2-aryl group.
Sirisoma N; Pervin A; Nguyen B; Crogan-Grundy C; Kasibhatla S; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Apr; 19(8):2305-9. PubMed ID: 19285392
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay.
Kemnitzer W; Jiang S; Zhang H; Kasibhatla S; Crogan-Grundy C; Blais C; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2008 Oct; 18(20):5571-5. PubMed ID: 18805007
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Kemnitzer W; Kuemmerle J; Jiang S; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jul; 19(13):3481-4. PubMed ID: 19467598
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents.
Kumar D; Patel G; Chavers AK; Chang KH; Shah K
Eur J Med Chem; 2011 Jul; 46(7):3085-92. PubMed ID: 21481985
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides.
Avanzo RE; Padrón JM; D'Accorso NB; Fascio ML
Bioorg Med Chem Lett; 2017 Aug; 27(16):3674-3677. PubMed ID: 28716494
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions.
Kemnitzer W; Kuemmerle J; Jiang S; Zhang HZ; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2008 Dec; 18(23):6259-64. PubMed ID: 18952423
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers.
Ewies EF; El-Hussieny M; El-Sayed NF; Fouad MA
Eur J Med Chem; 2019 Oct; 180():310-320. PubMed ID: 31323616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
